Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -382.32% is 481% below its 5-year average of -65.77%, near the low end of its 5-year range (-382.32%–-25.18%).
290.04% below its 12-month average of -98.02%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
-382.32%
RETURN ON ASSETS (ROA) AVG TTM
-98.02%
RETURN ON ASSETS (ROA) AVG 3Y
-80.35%
RETURN ON ASSETS (ROA) AVG 5Y
-65.77%
RETURN ON ASSETS (ROA) AVG 10Y
-60.60%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-290.04%
CURRENT VS 3Y AVG
-375.82%
CURRENT VS 5Y AVG
-481.27%
CURRENT VS 10Y AVG
-530.87%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
5.16%
median of 89 covered companies
CURRENT VS SECTOR MEDIAN
-7509.30%
vs the sector median at left
PDS Biotechnology Corporation
Market Cap
$11.79M
Return on Assets (ROA)
-382.32%
TTM Avg
-98.02%
3Y Avg
-80.35%
5Y Avg
-65.77%
Market Cap
$438.82M
Return on Assets (ROA)
-23.05%
TTM Avg
-30.00%
3Y Avg
-27.77%
5Y Avg
-27.77%
Market Cap
$492.43M
Return on Assets (ROA)
4.30%
TTM Avg
13.65%
3Y Avg
19.24%
5Y Avg
21.45%
Market Cap
$1.18B
Return on Assets (ROA)
-6.43%
TTM Avg
-17.46%
3Y Avg
-82.63%
5Y Avg
-55.94%
Market Cap
$2.23B
Return on Assets (ROA)
-10.49%
TTM Avg
-13.41%
3Y Avg
-10.26%
5Y Avg
-6.23%
Market Cap
$3.06B
Return on Assets (ROA)
10.36%
TTM Avg
11.11%
3Y Avg
1.40%
5Y Avg
-7.68%
Market Cap
$5.00B
Return on Assets (ROA)
15.41%
TTM Avg
17.55%
3Y Avg
14.67%
5Y Avg
15.71%
Market Cap
$5.40B
Return on Assets (ROA)
5.08%
TTM Avg
4.88%
3Y Avg
4.58%
5Y Avg
3.44%
Market Cap
$6.43B
Return on Assets (ROA)
-3.91%
TTM Avg
11.88%
3Y Avg
0.12%
5Y Avg
-6.73%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PDS Biotechnology Corporation (PDSB) | $11.79M | -382.32% | -98.02% | -80.35% | -65.77% |
| Shoulder Innovations, Inc. (SI)vs › | $438.82M | -23.05% | -30.00% | -27.77% | -27.77% |
| NRC Health (NRC)vs › | $492.43M | 4.30% | 13.65% | 19.24% | 21.45% |
| Teladoc Health, Inc. (TDOC)vs › | $1.18B | -6.43% | -17.46% | -82.63% | -55.94% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.23B | -10.49% | -13.41% | -10.26% | -6.23% |
| TransMedics Group, Inc. (TMDX)vs › | $3.06B | 10.36% | 11.11% | 1.40% | -7.68% |
| Doximity, Inc. (DOCS)vs › | $5.00B | 15.41% | 17.55% | 14.67% | 15.71% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.40B | 5.08% | 4.88% | 4.58% | 3.44% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.43B | -3.91% | 11.88% | 0.12% | -6.73% |
| Chemed Corporation (CHE)vs › | $6.84B | 17.41% | 17.14% | 16.98% | 18.36% |
ROA
-382.3%
ROE
-372.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -113.12% |
| 2024-12-31 | -82.92% |
| 2023-12-31 | -72.31% |
| 2022-12-31 | -53.05% |
| 2021-12-31 | -25.18% |
| 2020-12-31 | -48.06% |
| 2019-12-31 | -48.30% |
| 2018-12-31 | -112.83% |
| 2017-12-31 | -54.91% |
| 2016-12-31 | -35.00% |
| 2015-12-31 | -20.94% |
| 2014-12-31 | -71.57% |
| 2013-12-31 | -78.81% |
| 2012-12-31 | -2868.74% |
